Welcome to CDC Stacks | Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma - authors’ reply - 42169 | CDC Public Access | Arctic Investigations Program
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma - authors’ reply
  • Published Date:
    Sep 2016
  • Source:
    Aliment Pharmacol Ther. 44(6):650-651.


Public Access Version Available on: September 01, 2017 information icon
Please check back on the date listed above.
Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: